Search
for

    Sort by

    Research 571–600 of 1000+

    1. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness Nature communications · 2017 · 64 citations
    2. Pre-receptor regulation of the androgen receptor Molecular and cellular endocrinology · 2007 · 56 citations
    3. Significance of the polyglutamine tract polymorphism in the androgen receptor Urology · 2001 · 54 citations
    4. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    5. BIOLOGICAL ACTIVITY OF ANTIANDROGENS 1970 · 51 citations
    6. Selective non-steroidal inhibitors of 5α-reductase type 1 2004 · 49 citations
    7. 5α-Reduced glucocorticoids: a story of natural selection Journal of Endocrinology · 2011 · 46 citations
    8. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    9. Anabolic effects of testosterone are preserved during inhibition of 5α-reductase 2007 · 42 citations
    10. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    11. Antiandrogens: Clinical applications The Journal of Steroid Biochemistry and Molecular Biology · 1990 · 39 citations
    12. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients Cell Transplantation · 2020 · 38 citations
    13. Recent advances in thiasteroids chemistry Steroids · 2006 · 37 citations
    14. Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period The Journal of Urology · 2006 · 32 citations
    15. The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic Frontiers in Endocrinology · 2021 · 29 citations
    16. Effects of lifelong testosterone exposure on health and disease using Mendelian randomization eLife · 2020 · 29 citations
    17. CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism? The Journal of Sexual Medicine · 2013 · 29 citations
    18. Does a male polycystic ovarian syndrome equivalent exist? Journal of Endocrinological Investigation · 2017 · 28 citations
    19. Androgen antagonists in androgen target tissues Pharmacology & Therapeutics · 1984 · 27 citations
    20. Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids Endocrine, metabolic & immune disorders. Drug targets · 2006 · 26 citations
    21. Testosterone therapy in men: Clinical and pharmacological perspectives Journal of Endocrinological Investigation · 2000 · 25 citations
    22. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    23. Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry 2017 · 22 citations
    24. Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors Journal of Medicinal Chemistry · 2002 · 22 citations
    25. Disease Versus Disease: How One Disease May Ameliorate Another Pediatrics · 2006 · 21 citations
    26. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    27. Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i> Chemistry & Biodiversity · 2009 · 20 citations
    28. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    29. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    30. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations